Arcus Biosciences, Inc. RCUS
24.97
(0.09)
(0.36%)
as of 25 Sep
- Market cap
- $3.2B
- P/E
- 0.0×
Follow RCUS
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 58.65 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 0.00 | 44.64 | 29.51 | 18.24 | 7.32 | 12.99 | 12.45 | 5.20 | 10.36 |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 13.17 | 0.00 | 3.37 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | 1.99 | (52.46) | (46.74) | (28.42) | (45.28) | (20.78) | (16.55) | (13.42) | (21.33) |
P/B ratio |
— | 0.00 | 1.59 | 2.70 | 2.83 | 3.33 | 2.21 | 3.15 | 2.77 | 4.06 |
Price to Tangible BV |
— | 0.00 | 1.59 | 2.70 | 2.83 | 3.33 | 2.21 | 3.15 | 2.77 | 4.06 |
EV/Sales |
— | 0.00 | 13.92 | 16.96 | 9.09 | 6.33 | 5.02 | 6.96 | 1.60 | 6.79 |
EV/EBITDA |
— | 2.84 | 0.00 | 0.00 | 0.00 | 38.45 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | 5.77 | (2.70) | (3.46) | 6.39 | (9.46) | 1.28 | (2.66) | (2.42) | (3.48) |
EV/FCF |
— | 4.73 | (2.49) | (3.37) | 6.56 | (8.59) | 1.30 | (2.47) | (2.34) | (3.47) |
Quick Ratio |
17.91 | 13.81 | 15.15 | 8.31 | 6.00 | 7.49 | 5.43 | 4.33 | 4.42 | 4.29 |
Current Ratio |
17.98 | 13.90 | 15.29 | 8.49 | 6.05 | 7.60 | 5.53 | 4.52 | 4.50 | 4.36 |
Net Debt/EBITDA |
5.86 | 3.46 | 4.85 | 2.15 | 5.90 | (6.06) | 3.26 | 2.16 | 2.70 | 2.27 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 1.94% | 7.35% | 8.70% | 0.00% | 4.17% | 8.69% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.14 | 0.18 | 0.00 | 0.10 | 0.16 |
Asset Turnover |
0.00 | 0.01 | 0.04 | 0.06 | 0.16 | 0.32 | 0.08 | 0.10 | 0.23 | 0.22 |
Operating CF/Net income |
0.72 | 0.47 | 0.87 | 0.87 | (0.90) | (4.83) | (1.64) | 1.00 | 0.60 | 1.37 |
Capex/Depreciation |
(3.12) | (2.11) | (1.96) | (2.05) | (1.00) | (2.89) | (1.00) | 2.18 | 0.40 | 0.67 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 39.07% | 114.99% | (61.00%) | (42.48%) | (36.93%) | 7.89% | (35.62%) | (54.87%) | (59.77%) | (63.26%) | |
| (18.92%) | (55.73%) | (21.31%) | (35.44%) | (25.22%) | 4.48% | (18.18%) | (25.16%) | (25.21%) | (30.84%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 7.34% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(17.49%) | (30.27%) | (19.59%) | (47.24%) | (19.68%) | 4.70% | (29.37%) | (43.98%) | (33.81%) | (43.26%) |
Average Days of Receivables |
0.00 | 6.46 | 3.63 | 9.32 | 7.95 | 709.99 | 127.10 | 118.55 | 28.29 | 16.26 |
Research and Development Expense of Revenue |
0.00% | 3,341.68% | 594.35% | 523.21% | 203.85% | 67.10% | 257.14% | 290.60% | 173.64% | 211.74% |
Selling, General and Administrative Expense of Revenue |
0.00% | 540.41% | 162.41% | 168.19% | 55.13% | 18.80% | 92.86% | 100.00% | 46.51% | 44.53% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 35.03% | 46.38% | 59.87% | 28.21% | 14.36% | 58.04% | 62.39% | 29.46% | 24.29% |
Graham Net Nets |
— | 4.51 | 0.59 | 0.35 | 0.33 | 0.18 | 0.26 | 0.14 | 0.26 | 0.20 |
Graham Number |
— | 160.78 | 0.00 | 0.00 | 0.00 | 13.73 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (170.81%) | (20.61%) | (19.21%) | (9.05%) | 1.70% | (18.42%) | (21.09%) | (20.82%) | (13.85%) |
Free Cash Flow Yield |
— | (98.38%) | (12.54%) | (17.03%) | 7.59% | (10.06%) | 29.70% | (22.66%) | (13.12%) | (18.91%) |
Revenue per Share |
0.00 | 0.77 | 0.24 | 0.34 | 1.42 | 5.53 | 1.56 | 1.58 | 2.86 | 2.30 |
Operating CF per Share |
(14.98) | (13.71) | (1.24) | (1.68) | 2.03 | (3.69) | 6.08 | (4.14) | (1.89) | (4.49) |
Capex per Share |
(4.74) | (3.02) | (0.11) | (0.04) | (0.05) | (0.38) | (0.08) | (0.32) | (0.07) | (0.02) |
Free Cash Flow per Share |
(19.73) | (16.72) | (1.35) | (1.72) | 1.97 | (4.07) | 6.00 | (4.46) | (1.95) | (4.51) |
Cash per Share |
114.46 | 96.12 | 7.41 | 4.30 | 13.30 | 7.20 | 14.01 | 10.26 | 10.85 | 9.13 |
Shareholders Equity per Share |
0.00 | 84.17 | 6.79 | 3.74 | 9.17 | 12.15 | 9.13 | 6.24 | 5.38 | 5.88 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 84.17 | 6.79 | 3.74 | 9.17 | 12.15 | 9.13 | 6.24 | 5.38 | 5.88 |
Free Cash Flow |
(17.04) | (30.57) | (46.74) | (75.39) | 108.00 | (282.00) | 432.00 | (330.00) | (176.00) | (484.00) |
Working Capital |
94.15 | 164.14 | 242.01 | 170.00 | 614.15 | 1,096.00 | 874.00 | 647.00 | 790.00 | 776.00 |
Capital Expenditures |
(4.10) | (5.51) | (3.74) | (1.92) | (3.00) | (26.00) | (6.00) | (24.00) | (6.00) | (2.00) |
Net Current Asset Value |
99.69 | 140.25 | 218.97 | 153.44 | 465.83 | 512.00 | 379.00 | 198.00 | 351.00 | 499.00 |
EV/EBIT |
— | 2.71 | 0.00 | 0.00 | 0.00 | 44.86 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 3.90 | 0.45 | 0.13 | 0.04 | 0.07 | 0.05 | 0.21 | 0.02 | 0.01 |
Net Profit Margin |
0.00% | (3,756.69%) | (593.73%) | (564.73%) | (157.69%) | 13.84% | (238.39%) | (262.39%) | (109.69%) | (142.91%) |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 51.94 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.15 | 0.23 | 0.17 | 0.10 | 0.28 | 0.28 | 0.17 | (0.22) | (0.32) | (0.07) |
Cash ROIC |
(21.79%) | (11.01%) | (11.01%) | (23.51%) | 8.04% | (19.75%) | 22.60% | (29.24%) | (14.36%) | (30.51%) |
Accounts Receivable Turnover |
0.00 | 6.57 | 154.69 | 64.38 | 74.96 | 1.03 | 0.29 | 3.04 | 8.90 | 15.94 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | — | — | — | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | — | — | — | 0.00 | 0.00 | — | — | — |
Average Receivables |
0.20 | 0.22 | 0.05 | 0.23 | 1.04 | 373.35 | 392.00 | 38.50 | 29.00 | 15.50 |
Average Payables |
3.93 | 3.84 | 3.46 | 3.90 | 10.19 | 12.84 | 15.00 | 18.50 | 17.50 | 30.00 |
Average Assets |
95.00 | 95.24 | 232.71 | 239.02 | 487.70 | 1,182.15 | 1,468.50 | 1,220.00 | 1,122.50 | 1,144.50 |
Average Common Equity |
(46.00) | (46.16) | 81.31 | 199.39 | 333.07 | 672.15 | 749.50 | 559.50 | 473.50 | 558.00 |
Columns are period end dates